Phase 3 Pancreatitis Trial, Recruiting (NCT06861010)

Phase 3 Pancreatitis Trial, Recruiting NCT06861010 Sponsor: Tanta University Condition: Pancreatitis

Printed from Voxsanity (voxsanity.com.au) — NCT06861010 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You are male or female
Your doctor has recommended a procedure called ERCP (a scope procedure to examine the bile and pancreatic ducts) because of a suspected problem with your pancreas or bile ducts
Your blood test results for two pancreas-related substances (amylase and lipase) are in the normal range before the procedure

Who may not be able to join:

You are under 18 years old
You have diabetes that is not well controlled
You have a serious problem with blood clotting or bleeding
Your kidneys are not working well enough (based on specific blood and urine test results — confirm with trial site)
You have a serious heart condition
You have previously had a surgical cutting, widening, or stenting procedure on your bile or pancreatic ducts
You are currently pregnant or breastfeeding
You already have pancreatitis (inflammation of the pancreas) at the time of admission, before the ERCP procedure
You are unwilling to have the ERCP procedure
You have a known allergy to a medication called ondansetron

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06861010

Sponsor: Tanta University

Phase: Phase 3

Status: Recruiting

Condition: Pancreatitis

More information: https://clinicaltrials.gov/study/NCT06861010

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You are male or female
Your doctor has recommended a procedure called ERCP (a scope procedure to examine the bile and pancreatic ducts) because of a suspected problem with your pancreas or bile ducts
Your blood test results for two pancreas-related substances (amylase and lipase) are in the normal range before the procedure

Who may not be able to join:

You are under 18 years old
You have diabetes that is not well controlled
You have a serious problem with blood clotting or bleeding
Your kidneys are not working well enough (based on specific blood and urine test results — confirm with trial site)
You have a serious heart condition
You have previously had a surgical cutting, widening, or stenting procedure on your bile or pancreatic ducts
You are currently pregnant or breastfeeding
You already have pancreatitis (inflammation of the pancreas) at the time of admission, before the ERCP procedure
You are unwilling to have the ERCP procedure
You have a known allergy to a medication called ondansetron

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

Tanta University

Registry

ClinicalTrials.gov

Start date

1 March 2025

Est. completion

20 December 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

The primary outcome that will be measured is the development of pancreatitis after the procedure according to consensus criteria

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov